<DOC>
	<DOCNO>NCT02273804</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Topiramate decrease Body Mass Index compare placebo 9 month .</brief_summary>
	<brief_title>Topiramate Severe Obesity</brief_title>
	<detailed_description>Childhood obesity remain adulthood main case , associate early increase cardiovascular risk excess mortality young adult due stroke cancer . Bariatric surgery rare France child cause severe complication . Long term effect still unknown . Topiramate already use thousand child neurology , effect already well know , lethal complication report . The hypothesis Topiramate associate standard treatment obesity effective standard treatment alone . This 4.5-years , randomize , double-blind , placebo-controlled , clinical trial topiramate ( 9 month ) vs placebo ( 9months ) Body Mass Index reduction 160 adolescent ( age 9-17 year old ) severe obesity . The main objective evaluate efficacy Topiramate decrease Body Mass Index compare placebo 9 month . The secondary objective evaluate : - decrease Body Mass Index Z-score - tolerance Topiramate - effectiveness Topiramate weight decrease decrease Body Mass Index Body Mass Index Z-score 1 , 3 ,4 6 month - effectiveness Topiramate eat behaviour , physical activity , calculate validated questionnaire scale 6 9 month - pharmacokinetic Topiramate obese child adolescent</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>917 year old Body Mass Index Zscore ≥ 4 SD French reference Weight enrolment &gt; 50 kg Therapeutic failure &gt; 6 month For girl childbearing age , willing acceptable method contraception ( estrogens plus progestin ) Negative pregnancy test girl childbearing age Agreeing participate upon write informed consent Appropriate understanding study Syndromic secondary obesity Major neurological psychiatric disorder Current history suicidal thought/attempts Current history breakdown Previous bariatric surgery Severe hypercapnia Renal dysfunction Deformity urinary tract solitary kidney History renal lithiasis glaucoma Poorly control diabetic child adolescent ( HbA1c &gt; 10 % ) diabetic patient treat Metformine and/or glibenclamide Hepatic dysfunction Bicarbonate &lt; 16 mmol/L Known hypersensitivity active substance one excipients Intolerance saccharose Enrolment another therapeutic study High probability fail comply treatment Females : Pregnant , plan become pregnant No signature consent form Uncovered French National health Insurance system ( Sécurité sociale )</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Topiramate</keyword>
	<keyword>Obesity</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
</DOC>